用于化疗期间保留卵巢功能的促性腺激素释放激素激动剂。 - Suppr

Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy.

作者信息

Tomao Federica, Benedetti Panici Pierluigi, Tomao Silverio

出版信息

J Clin Oncol. 2012 Sep 10;30(26):3310-1; author reply 3312-3. doi: 10.1200/JCO.2012.42.2436. Epub 2012 May 29.

DOI:10.1200/JCO.2012.42.2436

PMID:22649128

Abstract

摘要

相似文献

Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy.

J Clin Oncol. 2012 Sep 10;30(26):3310-1; author reply 3312-3. doi: 10.1200/JCO.2012.42.2436. Epub 2012 May 29.

Gonadotropin-releasing hormone agonist for preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.

J Clin Oncol. 2012 Sep 10;30(26):3310; author reply 3312-3. doi: 10.1200/JCO.2012.41.8467. Epub 2012 May 29.

Potential late effect of gonadotropin-releasing hormone agonists in combination with chemotherapy for early breast cancer.

J Clin Oncol. 2012 Sep 10;30(26):3311-2. doi: 10.1200/JCO.2012.42.6197. Epub 2012 May 29.

Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy?

J Clin Oncol. 2012 Feb 10;30(5):479-81. doi: 10.1200/JCO.2011.37.9883. Epub 2012 Jan 9.

Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.

J Clin Oncol. 2012 Feb 10;30(5):533-8. doi: 10.1200/JCO.2011.34.6890. Epub 2012 Jan 9.

3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience.

Future Oncol. 2015;11(23):3109-12. doi: 10.2217/fon.15.261. Epub 2015 Nov 6.

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.

JAMA. 2011 Jul 20;306(3):269-76. doi: 10.1001/jama.2011.991.

Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial.

Obstet Gynecol. 2013 Jan;121(1):78-86. doi: 10.1097/aog.0b013e31827374e2.

GnRH analogue for chemotherapy-induced ovarian damage: too early to say?

Fertil Steril. 2009 Aug;92(2):e33; author reply e34. doi: 10.1016/j.fertnstert.2009.06.002.

Prevention of Premature Menopause and Preservation of Fertility in Young Cancer Survivors: Hopeful Though Modest Long-term Results.

JAMA. 2015;314(24):2625-7. doi: 10.1001/jama.2015.17299.

引用本文的文献

Fertility drugs, reproductive strategies and ovarian cancer risk.

J Ovarian Res. 2014 May 8;7:51. doi: 10.1186/1757-2215-7-51. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy.

作者信息

出版信息

相似文献

引用本文的文献